Cargando…

Effects of Estrogen, an ERα Agonist and Raloxifene on Pressure Overload Induced Cardiac Hypertrophy

The aim of this study was to investigate the effects of 17β-estradiol (E2), the selective ERα agonist 16α-LE2, and the selective estrogen receptor modulator (SERM) raloxifene on remodeling processes during the development of myocardial hypertrophy (MH) in a mouse model of pressure overload. Myocardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westphal, Christina, Schubert, Carola, Prelle, Katja, Penkalla, Adam, Fliegner, Daniela, Petrov, George, Regitz-Zagrosek, Vera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515519/ https://www.ncbi.nlm.nih.gov/pubmed/23227210 http://dx.doi.org/10.1371/journal.pone.0050802

Ejemplares similares

Sex-specific pathways in early cardiac response to pressure overload in mice
por: Witt, Henning, et al.
Publicado: (2008)

Sex differences and estrogen effects in cardiac mitochondria in human aortic stenosis and in the mouse heart
por: Fliegner, Daniela, et al.
Publicado: (2023)

Sex-specific regulation of cardiac microRNAs targeting mitochondrial proteins in pressure overload
por: Sanchez-Ruderisch, Hugo, et al.
Publicado: (2019)

Reduction of apoptosis and preservation of mitochondrial integrity under ischemia/reperfusion injury is mediated by estrogen receptor β
por: Schubert, Carola, et al.
Publicado: (2016)

Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy
por: Yang, Chongzhe, et al.
Publicado: (2022)

CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy
por: Westphal, Christina, et al.
Publicado: (2013)

CardioNet: A human metabolic network suited for the study of cardiomyocyte metabolism
por: Karlstädt, Anja, et al.
Publicado: (2012)

Antileishmanial Activity of the Estrogen Receptor Modulator Raloxifene
por: Reimão, Juliana Q., et al.
Publicado: (2014)

Microtubule Stabilization in Pressure Overload Cardiac Hypertrophy
por: Sato, Hiroshi, et al.
Publicado: (1997)

The role of androgens in pressure overload myocardial hypertrophy
por: Schafstedde, Marie, et al.
Publicado: (2023)

Unsettled Issues and Future Directions for Research on Cardiovascular Diseases in Women
por: Regitz-Zagrosek, Vera
Publicado: (2018)

Sex and Gender Differences in Heart Failure
por: Regitz-Zagrosek, Vera
Publicado: (2020)

Interstitial expansion in pressure overload left ventricular hypertrophy
por: Treibel, Thomas A, et al.
Publicado: (2013)

Anti-Estrogen Withdrawal Effect With Raloxifene? A Case Report
por: Lemmo, Walter
Publicado: (2016)

Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes
por: Regitz-Zagrosek, Vera, et al.
Publicado: (2022)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017)

SOCS3 Negatively Regulates Cardiac Hypertrophy via Targeting GRP78-Mediated ER Stress During Pressure Overload
por: Liu, Shuang, et al.
Publicado: (2021)

IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Dai, Jia, et al.
Publicado: (2013)

Intermedin Suppresses Pressure Overload Cardiac Hypertrophy through Activation of Autophagy
por: Chen, HuaLi, et al.
Publicado: (2013)

Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload
por: WU, CHUNTAO, et al.
Publicado: (2015)

Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling
por: Liu, Xin, et al.
Publicado: (2021)

Cardioprotective Effect of Selective Estrogen Receptor Modulator Raloxifene Are Mediated by Heme Oxygenase in Estrogen-Deficient Rat
por: Posa, Anikó, et al.
Publicado: (2017)

Rescue of Pressure Overload‐Induced Heart Failure by Estrogen Therapy
por: Iorga, Andrea, et al.
Publicado: (2016)

The Selective Estrogen Receptor Modulator Raloxifene Inhibits Neutrophil Extracellular Trap Formation
por: Flores, Roxana, et al.
Publicado: (2016)

Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene
por: Huo, Shengqi, et al.
Publicado: (2021)

Sex Differences in Cardiac Mitochondria in the New Zealand Obese Mouse
por: John, Cathleen, et al.
Publicado: (2018)

Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats
por: Hao, Jia, et al.
Publicado: (2007)

Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking ELTD1
por: Xiao, Jinfeng, et al.
Publicado: (2012)

Cellular hypertrophy occurs before interstitial fibrosis in pressure-overload heart failure
por: Shah, Ravi, et al.
Publicado: (2013)

The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy
por: Yang, Lei, et al.
Publicado: (2016)

2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy
por: Maayah, Zaid H., et al.
Publicado: (2018)

MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload
por: Ji, Yue, et al.
Publicado: (2018)

Protective Roles of Interferon‐γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload
por: Kimura, Akihiko, et al.
Publicado: (2018)

Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy
por: Zhang, Ji, et al.
Publicado: (2016)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
por: Guo, Xinji, et al.
Publicado: (2020)

Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II
por: Li, Shujun, et al.
Publicado: (2021)

Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy
por: Ma, Sai, et al.
Publicado: (2021)

Peroxiredoxin-5 Knockdown Accelerates Pressure Overload-Induced Cardiac Hypertrophy in Mice
por: Hu, Chengyun, et al.
Publicado: (2022)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
Publicado: (2022)

Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy
por: Zhen, Changlin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rs7gu7mv0mpen7ddi2bdh0n8tn